My question actually relates somewhat to the point I've made previously around Pharmac in terms of the cost-benefit model and the fact that the investment may be made within a health appropriation, but yet the benefit crystallises or is derived or is realised—three words meaning the same thing—outside of the health sphere. When I'm looking through the skill sets of the people within that advisory committee, there is no requirement for anyone with any health economics, financial sustainability, fiscal health, fiscal experience, or any such aspect. Noting that one of the most significant challenges that we have within the healthcare system globally is how to meet the fact that, in effect, demand for healthcare services is infinite and yet funding is finite—quite simply, that lens is important in terms of having that perspective around the table. You know, it can all sound nice in terms of blue-sky thinking of where we should be in terms of outcomes, but the reality is that we can't achieve everything within that finite health budget.